Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
21
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Kowalski Mark | Chief Medical Officer | 1 | $0 | $0 | 2017-01-03 |
| Parfet Donald R | Chairman of the Board | 59 | $0 | $0 | 2016-11-08 |
| You Angie | Chief Bus. & Strat. Officer | 2 | $0 | $0 | 2016-09-30 |
| Klencke Barbara | Chief Development Officer | 2 | $0 | $0 | 2016-09-30 |
| Glover Nicholas | CEO and President | 5 | $0 | $50.2K | 2016-09-30 |
| Jagpal Sukhi | Chief Financial Officer | 2 | $0 | $0 | 2016-09-30 |
| Topper James N | Director | 5 | $3.74M | $0 | 2016-06-16 |
| Pelzer Robert | Director | 1 | $0 | $0 | 2016-06-16 |
| ONETTO NICOLE | Director | 1 | $0 | $0 | 2016-06-16 |
| Nguyen Tran | Director | 1 | $0 | $0 | 2016-06-09 |
| Cooper Jeffrey H | Director | 1 | $0 | $0 | 2016-06-09 |
| Chapman Wendy | SVP Clinical Operations | 10 | $0 | $89.2K | 2016-03-22 |
| Lovejoy Chandra D | SVP of Reg. Affairs & Quality | 5 | $0 | $236.8K | 2016-03-08 |
| Messmann Richard A | Chief Medical Officer | 1 | $0 | $0 | 2016-03-08 |
| Rodigueza Wendi | Chief Scientific Officer | 5 | $0 | $29.6K | 2016-01-22 |
| Anderson Keith Edward | SVP, Technical Operations | 1 | $0 | $0 | 2015-12-01 |
| Vitangcol Alvin | Director | 8 | $0 | $0 | 2015-07-21 |
| OrbiMed Private Investments V, LP | Director | 4 | $2.98M | $0 | 2015-07-21 |
| Vivo Ventures VII Affiliates Fund, L.P. | Other | 8 | $3.74M | $0 | 2015-07-21 |
| CHA ALBERT | Director | 8 | $3.74M | $0 | 2015-07-21 |
| Thompson Peter A. | Director | 4 | $2.98M | $0 | 2015-07-21 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Kowalski Mark | Chief Medical Officer | A Award deriv | 2017-01-03 | 2017-01-04 | 300,000 | — | $0 | 300,000 | SEC↗ |
| Parfet Donald R | Chairman of the Board | J Other | 2016-11-08 | 2016-11-10 | 6,767 | — | $0 | 387,530 | SEC↗ |
| Parfet Donald R | Chairman of the Board | J Other | 2016-11-08 | 2016-11-10 | 3,383 | — | $0 | 3,383 | SEC↗ |
| Parfet Donald R | Chairman of the Board | J Other | 2016-11-08 | 2016-11-10 | 1,423 | — | $0 | 4,806 | SEC↗ |
| Parfet Donald R | Chairman of the Board | J Other | 2016-11-08 | 2016-11-10 | 2,403 | — | $0 | 75,855 | SEC↗ |
| Parfet Donald R | Chairman of the Board | J Other | 2016-11-08 | 2016-11-10 | 4,806 | — | $0 | 0 | SEC↗ |
| You Angie | Chief Bus. & Strat. Officer | A Award deriv | 2016-09-30 | 2016-10-04 | 200,000 | — | $0 | 200,000 | SEC↗ |
| Glover Nicholas | CEO and President | A Award deriv | 2016-09-30 | 2016-10-04 | 500,000 | — | $0 | 500,000 | SEC↗ |
| Klencke Barbara | Chief Development Officer | A Award deriv | 2016-09-30 | 2016-10-04 | 456,000 | — | $0 | 456,000 | SEC↗ |
| Jagpal Sukhi | Chief Financial Officer | A Award deriv | 2016-09-30 | 2016-10-04 | 168,000 | — | $0 | 168,000 | SEC↗ |
| Parfet Donald R | Chairman of the Board | J Other | 2016-09-29 | 2016-09-30 | 1,692 | — | $0 | 1,692 | SEC↗ |
| Parfet Donald R | Chairman of the Board | J Other | 2016-09-29 | 2016-09-30 | 711 | — | $0 | 2,403 | SEC↗ |
| Parfet Donald R | Chairman of the Board | J Other | 2016-09-29 | 2016-09-30 | 3,384 | — | $0 | 380,763 | SEC↗ |
| Parfet Donald R | Chairman of the Board | J Other | 2016-09-29 | 2016-09-30 | 1,202 | — | $0 | 73,452 | SEC↗ |
| Parfet Donald R | Chairman of the Board | J Other | 2016-09-29 | 2016-09-30 | 2,403 | — | $0 | 0 | SEC↗ |
| ONETTO NICOLE | Director | A Award deriv | 2016-06-16 | 2016-06-20 | 38,835 | — | $0 | 38,835 | SEC↗ |
| Parfet Donald R | Chairman of the Board | A Award deriv | 2016-06-16 | 2016-06-20 | 38,835 | — | $0 | 38,835 | SEC↗ |
| Pelzer Robert | Director | A Award deriv | 2016-06-16 | 2016-06-20 | 38,835 | — | $0 | 38,835 | SEC↗ |
| Topper James N | Director | A Award deriv | 2016-06-16 | 2016-06-20 | 38,835 | — | $0 | 38,835 | SEC↗ |
| Cooper Jeffrey H | Director | A Award deriv | 2016-06-09 | 2016-06-13 | 77,670 | — | $0 | 77,670 | SEC↗ |
| Nguyen Tran | Director | A Award deriv | 2016-06-09 | 2016-06-13 | 77,670 | — | $0 | 77,670 | SEC↗ |
| Parfet Donald R | Chairman of the Board | J Other | 2016-05-13 | 2016-05-17 | 3,204 | — | $0 | 377,379 | SEC↗ |
| Chapman Wendy | SVP Clinical Operations | M Exercise deriv | 2016-03-22 | 2016-03-24 | 3,000 | — | $0 | 76,248 | SEC↗ |
| Chapman Wendy | SVP Clinical Operations | M Exercise | 2016-03-22 | 2016-03-24 | 3,000 | $0.97 | $2.9K | 3,000 | SEC↗ |
| Chapman Wendy | SVP Clinical Operations | S Sale | 2016-03-22 | 2016-03-24 | 3,000 | $7.01 | $21.0K | 0 | SEC↗ |
| You Angie | Chief Bus. & Strat. Officer | A Award deriv | 2016-03-08 | 2016-03-10 | 75,000 | — | $0 | 75,000 | SEC↗ |
| Klencke Barbara | Chief Development Officer | A Award deriv | 2016-03-08 | 2016-03-10 | 82,500 | — | $0 | 82,500 | SEC↗ |
| Lovejoy Chandra D | SVP of Reg. Affairs & Qualit | A Award deriv | 2016-03-08 | 2016-03-10 | 31,000 | — | $0 | 31,000 | SEC↗ |
| Glover Nicholas | CEO and President | A Award deriv | 2016-03-08 | 2016-03-10 | 161,250 | — | $0 | 161,250 | SEC↗ |
| Messmann Richard A | Chief Medical Officer | A Award deriv | 2016-03-08 | 2016-03-10 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Jagpal Sukhi | Chief Financial Officer | A Award deriv | 2016-03-08 | 2016-03-10 | 48,750 | — | $0 | 48,750 | SEC↗ |
| Chapman Wendy | SVP Clinical Operations | A Award deriv | 2016-03-08 | 2016-03-10 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Chapman Wendy | SVP Clinical Operations | M Exercise deriv | 2016-02-22 | 2016-02-24 | 3,000 | — | $0 | 79,248 | SEC↗ |
| Chapman Wendy | SVP Clinical Operations | S Sale | 2016-02-22 | 2016-02-24 | 3,000 | $7.06 | $21.2K | 0 | SEC↗ |
| Chapman Wendy | SVP Clinical Operations | M Exercise | 2016-02-22 | 2016-02-24 | 3,000 | $0.97 | $2.9K | 3,000 | SEC↗ |
| Chapman Wendy | SVP Clinical Operations | M Exercise deriv | 2016-01-22 | 2016-01-25 | 5,000 | — | $0 | 82,248 | SEC↗ |
| Rodigueza Wendi | Chief Scientific Officer | S Sale | 2016-01-22 | 2016-01-22 | 1,000 | $9.66 | $9.7K | 156,276 | SEC↗ |
| Chapman Wendy | SVP Clinical Operations | S Sale | 2016-01-22 | 2016-01-25 | 5,000 | $9.39 | $47.0K | 0 | SEC↗ |
| Chapman Wendy | SVP Clinical Operations | M Exercise | 2016-01-22 | 2016-01-25 | 5,000 | $0.97 | $4.8K | 5,000 | SEC↗ |
| Rodigueza Wendi | Chief Scientific Officer | S Sale | 2016-01-21 | 2016-01-22 | 1,000 | $10.32 | $10.3K | 157,276 | SEC↗ |
| Rodigueza Wendi | Chief Scientific Officer | S Sale | 2016-01-20 | 2016-01-22 | 1,000 | $9.59 | $9.6K | 158,276 | SEC↗ |
| Glover Nicholas | CEO and President | M Exercise deriv | 2016-01-15 | 2016-01-19 | 5,000 | — | $0 | 864,219 | SEC↗ |
| Glover Nicholas | CEO and President | S Sale | 2016-01-15 | 2016-01-19 | 5,000 | $10.04 | $50.2K | 0 | SEC↗ |
| Glover Nicholas | CEO and President | M Exercise | 2016-01-15 | 2016-01-19 | 5,000 | $0.97 | $4.8K | 5,000 | SEC↗ |
| Lovejoy Chandra D | SVP of Reg. Affairs & Qualit | M Exercise deriv | 2016-01-12 | 2016-01-14 | 7,551 | — | $0 | 46,140 | SEC↗ |
| Lovejoy Chandra D | SVP of Reg. Affairs & Qualit | M Exercise | 2016-01-12 | 2016-01-14 | 7,551 | $0.97 | $7.3K | 20,973 | SEC↗ |
| Lovejoy Chandra D | SVP of Reg. Affairs & Qualit | S Sale | 2016-01-12 | 2016-01-14 | 15,411 | $11.06 | $170.4K | 5,562 | SEC↗ |
| Lovejoy Chandra D | SVP of Reg. Affairs & Qualit | S Sale | 2016-01-12 | 2016-01-14 | 5,562 | $11.93 | $66.4K | 0 | SEC↗ |
| Anderson Keith Edward | SVP, Technical Operations | A Award deriv | 2015-12-01 | 2015-12-02 | 100,000 | — | $0 | 100,000 | SEC↗ |
| CHA ALBERT | Director | C Conversion deriv | 2015-07-21 | 2015-07-21 | 44,991 | — | $0 | 0 | SEC↗ |
| CHA ALBERT | Director | C Conversion deriv | 2015-07-21 | 2015-07-21 | 2,064,308 | — | $0 | 0 | SEC↗ |
| OrbiMed Private Investments V, | Director | C Conversion deriv | 2015-07-21 | 2015-07-21 | 1,725,790 | — | $0 | 0 | SEC↗ |
| Parfet Donald R | Chairman of the Board | C Conversion deriv | 2015-07-21 | 2015-07-21 | 24,277 | — | $0 | 0 | SEC↗ |
| Parfet Donald R | Chairman of the Board | C Conversion deriv | 2015-07-21 | 2015-07-21 | 4,415 | — | $0 | 0 | SEC↗ |
| Parfet Donald R | Chairman of the Board | C Conversion deriv | 2015-07-21 | 2015-07-21 | 46,034 | — | $0 | 0 | SEC↗ |
| Parfet Donald R | Chairman of the Board | X Exercise deriv | 2015-07-21 | 2015-07-21 | 719 | — | $0 | 24,498 | SEC↗ |
| Parfet Donald R | Chairman of the Board | X Exercise deriv | 2015-07-21 | 2015-07-21 | 719 | $5.22 | $3.8K | 0 | SEC↗ |
| Parfet Donald R | Chairman of the Board | C Conversion deriv | 2015-07-21 | 2015-07-21 | 516,203 | — | $0 | 0 | SEC↗ |
| Parfet Donald R | Chairman of the Board | F Tax w/h deriv | 2015-07-21 | 2015-07-21 | 2,941 | — | $0 | 516,203 | SEC↗ |
| Parfet Donald R | Chairman of the Board | X Exercise deriv | 2015-07-21 | 2015-07-21 | 6,711 | — | $0 | 519,144 | SEC↗ |
| Parfet Donald R | Chairman of the Board | X Exercise deriv | 2015-07-21 | 2015-07-21 | 6,711 | $7.45 | $50.0K | 0 | SEC↗ |
| Parfet Donald R | Chairman of the Board | F Tax w/h deriv | 2015-07-21 | 2015-07-21 | 40,729 | — | $0 | 512,433 | SEC↗ |
| Parfet Donald R | Chairman of the Board | X Exercise deriv | 2015-07-21 | 2015-07-21 | 265,536 | — | $0 | 553,162 | SEC↗ |
| Parfet Donald R | Chairman of the Board | X Exercise deriv | 2015-07-21 | 2015-07-21 | 265,536 | $2.61 | $693.0K | 0 | SEC↗ |
| Parfet Donald R | Chairman of the Board | C Conversion deriv | 2015-07-21 | 2015-07-21 | 153,485 | — | $0 | 0 | SEC↗ |
| Parfet Donald R | Chairman of the Board | C Conversion deriv | 2015-07-21 | 2015-07-21 | 26,728 | — | $0 | 0 | SEC↗ |
| Parfet Donald R | Chairman of the Board | C Conversion deriv | 2015-07-21 | 2015-07-21 | 11,505 | — | $0 | 0 | SEC↗ |
| Parfet Donald R | Chairman of the Board | C Conversion deriv | 2015-07-21 | 2015-07-21 | 59,225 | — | $0 | 0 | SEC↗ |
| Parfet Donald R | Chairman of the Board | C Conversion deriv | 2015-07-21 | 2015-07-21 | 67,112 | — | $0 | 0 | SEC↗ |
| Parfet Donald R | Chairman of the Board | C Conversion deriv | 2015-07-21 | 2015-07-21 | 307 | — | $0 | 0 | SEC↗ |
| Parfet Donald R | Chairman of the Board | C Conversion deriv | 2015-07-21 | 2015-07-21 | 23,944 | — | $0 | 0 | SEC↗ |
| Parfet Donald R | Chairman of the Board | C Conversion deriv | 2015-07-21 | 2015-07-21 | 121,242 | — | $0 | 0 | SEC↗ |
| Parfet Donald R | Chairman of the Board | C Conversion deriv | 2015-07-21 | 2015-07-21 | 65,938 | — | $0 | 0 | SEC↗ |
| Parfet Donald R | Chairman of the Board | C Conversion deriv | 2015-07-21 | 2015-07-21 | 306 | — | $0 | 0 | SEC↗ |
| Parfet Donald R | Chairman of the Board | C Conversion deriv | 2015-07-21 | 2015-07-21 | 189,933 | — | $0 | 0 | SEC↗ |
| Parfet Donald R | Chairman of the Board | C Conversion deriv | 2015-07-21 | 2015-07-21 | 142,422 | — | $0 | 0 | SEC↗ |
| Parfet Donald R | Chairman of the Board | F Tax w/h deriv | 2015-07-21 | 2015-07-21 | 221 | — | $0 | 24,277 | SEC↗ |
| Parfet Donald R | Chairman of the Board | C Conversion deriv | 2015-07-21 | 2015-07-21 | 13,130 | — | $0 | 0 | SEC↗ |
| Rodigueza Wendi | Chief Scientific Officer | C Conversion deriv | 2015-07-21 | 2015-07-21 | 1,966 | — | $0 | 0 | SEC↗ |
| Thompson Peter A. | Director | C Conversion deriv | 2015-07-21 | 2015-07-21 | 1,725,790 | — | $0 | 0 | SEC↗ |
| Topper James N | Director | C Conversion deriv | 2015-07-21 | 2015-07-21 | 1,869,606 | — | $0 | 0 | SEC↗ |
| Vitangcol Alvin | Director | C Conversion deriv | 2015-07-21 | 2015-07-21 | 471,242 | — | $0 | 0 | SEC↗ |
| Vitangcol Alvin | Director | C Conversion deriv | 2015-07-21 | 2015-07-21 | 287,631 | — | $0 | 0 | SEC↗ |
| Vitangcol Alvin | Director | F Tax w/h deriv | 2015-07-21 | 2015-07-21 | 38,824 | — | $0 | 471,242 | SEC↗ |
| Vitangcol Alvin | Director | X Exercise deriv | 2015-07-21 | 2015-07-21 | 126,558 | — | $0 | 510,066 | SEC↗ |
| Vitangcol Alvin | Director | X Exercise deriv | 2015-07-21 | 2015-07-21 | 126,558 | $5.22 | $660.6K | 0 | SEC↗ |
| Vivo Ventures VII Affiliates F | Other | C Conversion deriv | 2015-07-21 | 2015-07-21 | 2,064,308 | — | $0 | 0 | SEC↗ |
| Vivo Ventures VII Affiliates F | Other | C Conversion deriv | 2015-07-21 | 2015-07-21 | 44,991 | — | $0 | 0 | SEC↗ |
| CHA ALBERT | Director | J Other | 2015-07-21 | 2015-07-21 | 106,647 | $5.22 | $556.7K | 2,215,946 | SEC↗ |
| CHA ALBERT | Director | J Other | 2015-07-21 | 2015-07-21 | 2,324 | $5.22 | $12.1K | 2,218,270 | SEC↗ |
| CHA ALBERT | Director | P Buy | 2015-07-21 | 2015-07-21 | 215,307 | $17.00 | $3.66M | 2,433,577 | SEC↗ |
| CHA ALBERT | Director | P Buy | 2015-07-21 | 2015-07-21 | 4,693 | $17.00 | $79.8K | 2,438,270 | SEC↗ |
| CHA ALBERT | Director | C Conversion | 2015-07-21 | 2015-07-21 | 44,991 | — | $0 | 2,109,299 | SEC↗ |
| CHA ALBERT | Director | C Conversion | 2015-07-21 | 2015-07-21 | 2,064,308 | — | $0 | 2,064,308 | SEC↗ |
| OrbiMed Private Investments V, | Director | J Other | 2015-07-21 | 2015-07-21 | 89,159 | $5.22 | $465.4K | 1,814,949 | SEC↗ |
| OrbiMed Private Investments V, | Director | P Buy | 2015-07-21 | 2015-07-21 | 175,000 | $17.00 | $2.98M | 1,989,949 | SEC↗ |
| OrbiMed Private Investments V, | Director | C Conversion | 2015-07-21 | 2015-07-21 | 1,725,790 | — | $0 | 1,725,790 | SEC↗ |
| Parfet Donald R | Chairman of the Board | C Conversion | 2015-07-21 | 2015-07-21 | 59,225 | — | $0 | 126,337 | SEC↗ |
| Parfet Donald R | Chairman of the Board | C Conversion | 2015-07-21 | 2015-07-21 | 67,112 | — | $0 | 67,112 | SEC↗ |
| Parfet Donald R | Chairman of the Board | C Conversion | 2015-07-21 | 2015-07-21 | 345 | — | $0 | 589 | SEC↗ |
| Parfet Donald R | Chairman of the Board | J Other | 2015-07-21 | 2015-07-21 | 819 | $5.22 | $4.3K | 65,779 | SEC↗ |
| Parfet Donald R | Chairman of the Board | C Conversion | 2015-07-21 | 2015-07-21 | 13,130 | — | $0 | 64,960 | SEC↗ |
| Parfet Donald R | Chairman of the Board | C Conversion | 2015-07-21 | 2015-07-21 | 51,830 | — | $0 | 51,830 | SEC↗ |
| Parfet Donald R | Chairman of the Board | C Conversion | 2015-07-21 | 2015-07-21 | 142,422 | — | $0 | 353,802 | SEC↗ |
| Parfet Donald R | Chairman of the Board | C Conversion | 2015-07-21 | 2015-07-21 | 211,036 | — | $0 | 211,380 | SEC↗ |
| Parfet Donald R | Chairman of the Board | C Conversion | 2015-07-21 | 2015-07-21 | 344 | — | $0 | 344 | SEC↗ |
| Parfet Donald R | Chairman of the Board | J Other | 2015-07-21 | 2015-07-21 | 4,119 | $5.22 | $21.5K | 217,903 | SEC↗ |
| Parfet Donald R | Chairman of the Board | C Conversion | 2015-07-21 | 2015-07-21 | 65,938 | — | $0 | 213,784 | SEC↗ |
| Parfet Donald R | Chairman of the Board | C Conversion | 2015-07-21 | 2015-07-21 | 121,242 | — | $0 | 147,846 | SEC↗ |
| Parfet Donald R | Chairman of the Board | C Conversion | 2015-07-21 | 2015-07-21 | 26,604 | — | $0 | 26,604 | SEC↗ |
| Parfet Donald R | Chairman of the Board | C Conversion | 2015-07-21 | 2015-07-21 | 4,970 | — | $0 | 4,970 | SEC↗ |
| Parfet Donald R | Chairman of the Board | J Other | 2015-07-21 | 2015-07-21 | 1,552 | $5.22 | $8.1K | 770,045 | SEC↗ |
| Parfet Donald R | Chairman of the Board | C Conversion | 2015-07-21 | 2015-07-21 | 24,277 | — | $0 | 768,493 | SEC↗ |
| Parfet Donald R | Chairman of the Board | C Conversion | 2015-07-21 | 2015-07-21 | 516,203 | — | $0 | 744,216 | SEC↗ |
| Parfet Donald R | Chairman of the Board | C Conversion | 2015-07-21 | 2015-07-21 | 170,538 | — | $0 | 228,013 | SEC↗ |
| Parfet Donald R | Chairman of the Board | C Conversion | 2015-07-21 | 2015-07-21 | 30,093 | — | $0 | 57,475 | SEC↗ |
| Parfet Donald R | Chairman of the Board | J Other | 2015-07-21 | 2015-07-21 | 4,413 | $5.22 | $23.0K | 142,255 | SEC↗ |
| Parfet Donald R | Chairman of the Board | C Conversion | 2015-07-21 | 2015-07-21 | 11,505 | — | $0 | 137,842 | SEC↗ |
| Rodigueza Wendi | Chief Scientific Officer | C Conversion | 2015-07-21 | 2015-07-21 | 1,966 | — | $0 | 159,276 | SEC↗ |
| Thompson Peter A. | Director | C Conversion | 2015-07-21 | 2015-07-21 | 1,725,790 | — | $0 | 1,725,790 | SEC↗ |
| Thompson Peter A. | Director | J Other | 2015-07-21 | 2015-07-21 | 89,159 | $5.22 | $465.4K | 1,814,949 | SEC↗ |
| Thompson Peter A. | Director | P Buy | 2015-07-21 | 2015-07-21 | 175,000 | $17.00 | $2.98M | 1,989,949 | SEC↗ |
| Topper James N | Director | J Other | 2015-07-21 | 2015-07-21 | 96,589 | $5.22 | $504.2K | 1,966,195 | SEC↗ |
| Topper James N | Director | P Buy | 2015-07-21 | 2015-07-21 | 220,000 | $17.00 | $3.74M | 2,186,195 | SEC↗ |
| Topper James N | Director | C Conversion | 2015-07-21 | 2015-07-21 | 1,869,606 | — | $0 | 1,869,606 | SEC↗ |
| Vitangcol Alvin | Director | J Other | 2015-07-21 | 2015-07-21 | 39,889 | $5.22 | $208.2K | 798,762 | SEC↗ |
| Vitangcol Alvin | Director | C Conversion | 2015-07-21 | 2015-07-21 | 471,242 | — | $0 | 471,242 | SEC↗ |
| Vitangcol Alvin | Director | C Conversion | 2015-07-21 | 2015-07-21 | 287,631 | — | $0 | 758,873 | SEC↗ |
| Vivo Ventures VII Affiliates F | Other | C Conversion | 2015-07-21 | 2015-07-21 | 2,064,308 | — | $0 | 2,064,308 | SEC↗ |
| Vivo Ventures VII Affiliates F | Other | C Conversion | 2015-07-21 | 2015-07-21 | 44,991 | — | $0 | 2,109,299 | SEC↗ |
| Vivo Ventures VII Affiliates F | Other | J Other | 2015-07-21 | 2015-07-21 | 2,324 | $5.22 | $12.1K | 2,218,270 | SEC↗ |
| Vivo Ventures VII Affiliates F | Other | P Buy | 2015-07-21 | 2015-07-21 | 215,307 | $17.00 | $3.66M | 2,433,577 | SEC↗ |
| Vivo Ventures VII Affiliates F | Other | P Buy | 2015-07-21 | 2015-07-21 | 4,693 | $17.00 | $79.8K | 2,438,270 | SEC↗ |
| Vivo Ventures VII Affiliates F | Other | J Other | 2015-07-21 | 2015-07-21 | 106,647 | $5.22 | $556.7K | 2,215,946 | SEC↗ |